search button

The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies

  • Authors:
    • Chunyan Fang
    • Wenqi Sun
    • Huirong Han
    • Lihong Shi
    • Lin Wang
    • Yan Zhao
    • Yang Tan

  • View Affiliations

  • Published online on: July 17, 2012     https://doi.org/10.3892/etm.2012.638
  • Pages: 728-732
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The aim of this study was to examine the association between the -149C>T polymorphism of DNA methyltransferase 3B (DNMT3B) and colorectal cancer (CRC) susceptibility. A comprehensive search was conducted to identify all case-control studies of the -149C>T polymorphism of DNMT3B and CRC risk. Statistical analysis was performed with the software program Stata (version 12.0) and Review Manager (version 5.0). A total of seven eligible studies, including 2,666 cases and 4,022 controls, associating the DNMT3B polymorphism of -149C>T with the risk of CRC were identified. These studies suggested no significant associations between the -149C>T polymorphism of the DNMT3B gene and the risk of developing CRC in the recessive, dominant and co-dominant models [for CC vs. TT: odds ratio (OR), 0.90; 95% confidence interval (CI), 0.90-1.25; P=0.37; for the recessive model: OR, 0.54, 95% CI, 0.28-1.04; P﹤0.00001; for the dominant model: OR, 1.07; 95% CI, 0.93-1.23; P=0.83 and C allele vs. T allele: OR, 0.70; 95% CI, 0.43-1.13; P﹤0.00001]. In the subgroup analysis, no significant associations were found in the European populations (for CC vs. TT: OR, 1.09; 95% CI, 0.92-1.30; P=0.88; for the recessive model: OR, 1.00; 95% CI, 0.88-1.13; P=0.14; for the dominant model: OR, 1.50; 95% CI, 0.89-2.54; P﹤0.00001 and C allele vs. T allele: OR, 0.70; 95% CI, 0.38-1.28; P﹤0.00001). No significant association was found between the -149C>T polymorphism in DNMT3B and CRC susceptibility.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 4 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Fang C, Sun W, Han H, Shi L, Wang L, Zhao Y and Tan Y: The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies. Exp Ther Med 4: 728-732, 2012
APA
Fang, C., Sun, W., Han, H., Shi, L., Wang, L., Zhao, Y., & Tan, Y. (2012). The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies. Experimental and Therapeutic Medicine, 4, 728-732. https://doi.org/10.3892/etm.2012.638
MLA
Fang, C., Sun, W., Han, H., Shi, L., Wang, L., Zhao, Y., Tan, Y."The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies". Experimental and Therapeutic Medicine 4.4 (2012): 728-732.
Chicago
Fang, C., Sun, W., Han, H., Shi, L., Wang, L., Zhao, Y., Tan, Y."The -149C>T polymorphism of DNMT3B is not associated with colorectal cancer risk: Evidence from a meta-analysis based on case-control studies". Experimental and Therapeutic Medicine 4, no. 4 (2012): 728-732. https://doi.org/10.3892/etm.2012.638